Carbonic Anhydrase Inhibitor [EPC]

Carbonic Anhydrase Inhibitor [EPC] was reported 20245 times

These side effects are most commonly reported by patients taking drugs of the Carbonic Anhydrase Inhibitor [EPC] class:

# Drug class Count
0 TREATMENT FAILURE 1812
1 DRUG INEFFECTIVE 1560
2 OFF LABEL USE 1166
3 FATIGUE 1129
4 DYSPNOEA 1013
5 DIZZINESS 969
6 HEADACHE 946
7 NAUSEA 830
8 EYE PAIN 809
9 VISION BLURRED 809
10 DIARRHOEA 795
11 ASTHENIA 738
12 FALL 732
13 EYE IRRITATION 676
14 MALAISE 637
15 INTRAOCULAR PRESSURE INCREASED 631
16 OCULAR HYPERAEMIA 613
17 SOMNOLENCE 582
18 CONDITION AGGRAVATED 557
19 VOMITING 552
20 ARTHRALGIA 550
21 VISUAL IMPAIRMENT 522
22 BLINDNESS 511
23 GLAUCOMA 505
24 COUGH 496
25 PAIN 485
26 PARAESTHESIA 484
27 HYPERSENSITIVITY 469
28 INSOMNIA 459
29 PYREXIA 449
30 PRURITUS 445
31 DECREASED APPETITE 425
32 BLOOD PRESSURE INCREASED 400
33 ABDOMINAL PAIN 373
34 MYALGIA 366
35 CONFUSIONAL STATE 365
36 DEATH 362
37 OCULAR DISCOMFORT 360
38 ABDOMINAL PAIN UPPER 358
39 SYNCOPE 347
40 CATARACT 335
41 DRUG INTERACTION 332
42 FEELING ABNORMAL 322
43 TACHYCARDIA 319
44 CHILLS 312
45 TINNITUS 303
46 PAIN IN EXTREMITY 294
47 MUSCULAR WEAKNESS 289
48 PRODUCT USE IN UNAPPROVED INDICATION 287
49 DRUG HYPERSENSITIVITY 286
50 COMA 284
51 SEPSIS 281
52 HEAD DISCOMFORT 275
53 HYPOTENSION 271
54 DIPLOPIA 270
55 WEIGHT DECREASED 270
56 PHOTOPHOBIA 269
57 ACUTE KIDNEY INJURY 266
58 PNEUMONIA 266
59 RASH 264
60 CARDIO-RESPIRATORY ARREST 261
61 HAEMATEMESIS 260
62 HAEMORRHAGIC STROKE 257
63 PRODUCT DOSE OMISSION ISSUE 254
64 ANXIETY 249
65 HYPERTENSION 249
66 ALTERED STATE OF CONSCIOUSNESS 243
67 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 242
68 GAIT DISTURBANCE 239
69 VISUAL ACUITY REDUCED 237
70 ASCITES 235
71 METABOLIC ACIDOSIS 234
72 BACK PAIN 233
73 AMAUROSIS FUGAX 231
74 PRESYNCOPE 230
75 EYE PRURITUS 228
76 HYPOAESTHESIA 227
77 HAEMATURIA 226
78 GENERALISED OEDEMA 224
79 DRY EYE 222
80 DRY MOUTH 221
81 HYPOKALAEMIA 213
82 DISEASE RECURRENCE 212
83 ABDOMINAL DISCOMFORT 211
84 NASOPHARYNGITIS 209
85 DEPRESSION 208
86 URINARY TRACT DISORDER 200
87 ASTHMA 197
88 DYSGEUSIA 195
89 HAEMOGLOBIN DECREASED 190
90 CHEST PAIN 187
91 LACRIMATION INCREASED 184
92 MUSCLE SPASMS 181
93 MEMORY IMPAIRMENT 173
94 URINARY TRACT INFECTION 170
95 BRADYCARDIA 169
96 ANAEMIA 168
97 DEHYDRATION 167
98 COVID-19 162
99 DRUG INTOLERANCE 162
100 EYE SWELLING 161
101 PALPITATIONS 159
102 CONSTIPATION 158
103 ATRIAL FIBRILLATION 157
104 LOSS OF CONSCIOUSNESS 156
105 TREMOR 156
106 EYE DISORDER 154
107 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 152
108 RENAL FAILURE 148
109 PRODUCT QUALITY ISSUE 145
110 SINUSITIS 144
111 ERYTHEMA 143
112 PRODUCT USE ISSUE 142
113 WEIGHT INCREASED 142
114 TOXICITY TO VARIOUS AGENTS 140
115 CEREBROVASCULAR ACCIDENT 137
116 RENAL IMPAIRMENT 137
117 BALANCE DISORDER 135
118 SEIZURE 135
119 BLINDNESS UNILATERAL 133
120 BLOOD POTASSIUM DECREASED 132
121 BLOOD PRESSURE DECREASED 132
122 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 128
123 MIGRAINE 127
124 ALOPECIA 125
125 CHRONIC KIDNEY DISEASE 125
126 EYE ALLERGY 125
127 OROPHARYNGEAL PAIN 123
128 HEART RATE INCREASED 122
129 GENERAL PHYSICAL HEALTH DETERIORATION 121
130 FOREIGN BODY SENSATION IN EYES 120
131 INCORRECT DOSE ADMINISTERED 120
132 UVEITIS 119
133 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 118
134 DISEASE PROGRESSION 117
135 LUNG DISORDER 116
136 DYSPEPSIA 114
137 INTENTIONAL PRODUCT USE ISSUE 114
138 TOXIC EPIDERMAL NECROLYSIS 114
139 INFLUENZA 113
140 WHEEZING 113
141 PERIPHERAL SWELLING 112
142 JOINT SWELLING 109
143 THROMBOSIS 109
144 ANGLE CLOSURE GLAUCOMA 108
145 PARALYSIS 108
146 HYPONATRAEMIA 106
147 NO ADVERSE EVENT 106
148 RHINORRHOEA 106
149 EPISTAXIS 105
150 INFECTION 104
151 MUSCULOSKELETAL STIFFNESS 104
152 NEPHROLITHIASIS 103
153 RESPIRATORY FAILURE 103
154 CARDIAC DISORDER 101
155 PRODUCTIVE COUGH 101
156 DIABETES MELLITUS 100
157 DYSPHAGIA 100
158 EYE DISCHARGE 100
159 OEDEMA PERIPHERAL 100
160 HYPOACUSIS 99
161 CHEST DISCOMFORT 98
162 LETHARGY 98
163 BLOOD GLUCOSE INCREASED 97
164 HOSPITALISATION 97
165 VERTIGO 97
166 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 96
167 THERAPY NON-RESPONDER 96
168 MYOCARDIAL INFARCTION 95
169 HEART RATE DECREASED 94
170 INJECTION SITE PAIN 93
171 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 93
172 PULMONARY EMBOLISM 93
173 CHOROIDAL EFFUSION 91
174 FOETAL EXPOSURE DURING PREGNANCY 91
175 ILLNESS 90
176 HYPOXIA 89
177 INTRACRANIAL PRESSURE INCREASED 89
178 CONTUSION 88
179 SWELLING 88
180 CONJUNCTIVITIS 87
181 ARRHYTHMIA 86
182 HALLUCINATION 86
183 CORNEAL OEDEMA 85
184 GASTROINTESTINAL HAEMORRHAGE 85
185 CARDIAC FAILURE 84
186 GASTROOESOPHAGEAL REFLUX DISEASE 84
187 OXYGEN SATURATION DECREASED 84
188 BLOOD CREATININE INCREASED 83
189 STRESS 83
190 CARDIAC FAILURE CONGESTIVE 82
191 HYPERHIDROSIS 82
192 NEUROPATHY PERIPHERAL 82
193 THROAT IRRITATION 82
194 ARTHRITIS 81
195 COGNITIVE DISORDER 81
196 URTICARIA 81
197 CONJUNCTIVAL HYPERAEMIA 80
198 DYSPHONIA 80
199 VISUAL FIELD DEFECT 80
200 BURNING SENSATION 79
201 OVERDOSE 79
202 SLEEP DISORDER 79
203 AMNESIA 78
204 DISTURBANCE IN ATTENTION 78
205 MEDICATION ERROR 78
206 BRONCHITIS 77
207 IRRITABILITY 74
208 CHOROIDAL DETACHMENT 72
209 PLEURAL EFFUSION 72
210 EYE INFLAMMATION 70
211 GASTROINTESTINAL DISORDER 70
212 INTENTIONAL PRODUCT MISUSE 70
213 PRODUCT CONTAINER ISSUE 70
214 SWELLING FACE 70
215 RASH ERYTHEMATOUS 69
216 EYE HAEMORRHAGE 68
217 SPEECH DISORDER 68
218 THROMBOCYTOPENIA 68
219 PAPILLOEDEMA 67
220 DRUG DOSE OMISSION 66
221 IDIOPATHIC INTRACRANIAL HYPERTENSION 66
222 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 65
223 THERAPY PARTIAL RESPONDER 65
224 HOT FLUSH 64
225 NASAL CONGESTION 64
226 HYPOTHYROIDISM 63
227 PRODUCT DOSE OMISSION 63
228 ACCIDENTAL EXPOSURE TO PRODUCT 62
229 NECK PAIN 62
230 PANCREATITIS ACUTE 62
231 ABDOMINAL DISTENSION 61
232 DYSPNOEA EXERTIONAL 61
233 EYE INFECTION 61
234 HEAD INJURY 61
235 HEART RATE IRREGULAR 61
236 HYPERKALAEMIA 61
237 TASTE DISORDER 60
238 CONJUNCTIVITIS ALLERGIC 59
239 INTRAOCULAR PRESSURE DECREASED 59
240 NERVOUSNESS 59
241 ACUTE RESPIRATORY FAILURE 58
242 CARDIAC ARREST 58
243 HAEMOPTYSIS 58
244 RETINAL DETACHMENT 58
245 THERAPEUTIC PRODUCT EFFECT DECREASED 58
246 DEPRESSED MOOD 57
247 NEUTROPENIA 57
248 PRODUCT PACKAGING QUANTITY ISSUE 57
249 RASH PAPULAR 57
250 APHASIA 56
251 EXPIRED PRODUCT ADMINISTERED 56
252 HYPOGLYCAEMIA 56
253 PLATELET COUNT DECREASED 56
254 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 56
255 THERAPEUTIC RESPONSE DECREASED 56
256 TREATMENT NONCOMPLIANCE 56
257 BLOOD PRESSURE FLUCTUATION 55
258 EYELID MARGIN CRUSTING 55
259 UNDERDOSE 55
260 EYELID OEDEMA 54
261 FLUID RETENTION 54
262 UNEVALUABLE EVENT 54
263 WHITE BLOOD CELL COUNT DECREASED 54
264 DISORIENTATION 53
265 ERYTHEMA OF EYELID 53
266 RENAL FAILURE ACUTE 53
267 AGITATION 52
268 HAEMORRHAGE 52
269 LIVER DISORDER 52
270 PRODUCT SUBSTITUTION ISSUE 52
271 PULMONARY OEDEMA 52
272 TRANSIENT ISCHAEMIC ATTACK 52
273 HYPOPHAGIA 51
274 LIQUID PRODUCT PHYSICAL ISSUE 51
275 INFLUENZA LIKE ILLNESS 50
276 OEDEMA 50
277 PANCYTOPENIA 50
278 PULMONARY FIBROSIS 50
279 SKIN DISCOLOURATION 50
280 ADVERSE DRUG REACTION 49
281 AGGRESSION 49
282 FUNGAL INFECTION 49
283 INFUSION RELATED REACTION 49
284 OCULAR HYPERTENSION 49
285 POLLAKIURIA 49
286 IRIDOCYCLITIS 48
287 OBSTRUCTIVE AIRWAYS DISORDER 48
288 PNEUMONIA ASPIRATION 48
289 SEPTIC SHOCK 48
290 ELECTROLYTE IMBALANCE 47
291 ENCEPHALOPATHY 47
292 FEBRILE NEUTROPENIA 47
293 ARTERIOSCLEROSIS CORONARY ARTERY 46
294 EPILEPSY 46
295 HYPERGLYCAEMIA 46
296 MACULAR DEGENERATION 46
297 MACULAR OEDEMA 46
298 MIDDLE INSOMNIA 46
299 MOBILITY DECREASED 46
300 RESPIRATORY DISTRESS 46
301 RHEUMATOID ARTHRITIS 46
302 DYSKINESIA 45
303 END STAGE RENAL DISEASE 45
304 EXPOSURE DURING PREGNANCY 45
305 HYPERAESTHESIA 45
306 PANIC ATTACK 45
307 UPPER RESPIRATORY TRACT INFECTION 45
308 CORNEAL DISORDER 44
309 DELIRIUM 44
310 DYSARTHRIA 44
311 FULL BLOOD COUNT ABNORMAL 44
312 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 44
313 MUSCULOSKELETAL PAIN 44
314 SUICIDAL IDEATION 44
315 ADVERSE EVENT 43
316 DEAFNESS 43
317 FEELING COLD 43
318 FLATULENCE 43
319 PUNCTATE KERATITIS 43
320 SURGERY 43
321 ALANINE AMINOTRANSFERASE INCREASED 42
322 BLISTER 42
323 NEUROLOGICAL SYMPTOM 42
324 CELLULITIS 41
325 DISCOMFORT 41
326 DRUG RESISTANCE 41
327 DRY SKIN 41
328 FLUSHING 41
329 HAEMATOMA 41
330 HAIR FOLLICLE TUMOUR BENIGN 41
331 HERPES ZOSTER 41
332 MENTAL STATUS CHANGES 41
333 MUSCLE TWITCHING 41
334 PRODUCT STORAGE ERROR 41
335 RESPIRATORY TRACT INFECTION 41
336 ARTERIOSCLEROSIS 40
337 ASPARTATE AMINOTRANSFERASE INCREASED 40
338 DEMENTIA 40
339 MATERNAL EXPOSURE DURING PREGNANCY 40
340 PANCREATITIS 40
341 PRESCRIBED UNDERDOSE 40
342 RECTAL HAEMORRHAGE 40
343 VASCULITIS 40
344 BRAIN FOG 39
345 CORNEAL OPACITY 39
346 DEEP VEIN THROMBOSIS 39
347 DEPRESSED LEVEL OF CONSCIOUSNESS 39
348 INTRAOCULAR PRESSURE TEST ABNORMAL 39
349 PRODUCT ADMINISTRATION ERROR 39
350 PSORIASIS 39
351 RENAL DISORDER 39
352 DYSURIA 38
353 EAR PAIN 38
354 INFLAMMATION 38
355 INJURY 38
356 INTENTIONAL DOSE OMISSION 38
357 STOMATITIS 38
358 SWOLLEN TONGUE 38
359 ACNE 37
360 BLEPHARITIS 37
361 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 37
362 FEELING HOT 37
363 HAEMATOCHEZIA 37
364 HYPERCAPNIA 37
365 HYPOTONIA 37
366 INTERNATIONAL NORMALISED RATIO INCREASED 37
367 LOWER RESPIRATORY TRACT INFECTION 37
368 PSYCHOTIC DISORDER 37
369 RENAL INJURY 37
370 SKIN EXFOLIATION 37
371 SLEEP APNOEA SYNDROME 37
372 THERAPEUTIC RESPONSE UNEXPECTED 37
373 ULCER 37
374 ABNORMAL SENSATION IN EYE 36
375 ANGER 36
376 ANGINA PECTORIS 36
377 BLOOD CHOLESTEROL INCREASED 36
378 BONE PAIN 36
379 EMOTIONAL DISTRESS 36
380 HALLUCINATION, VISUAL 36
381 LACTIC ACIDOSIS 36
382 NIGHTMARE 36
383 POOR VENOUS ACCESS 36
384 PRODUCT USE COMPLAINT 36
385 PULMONARY ALVEOLAR HAEMORRHAGE 36
386 STEVENS-JOHNSON SYNDROME 36
387 CONVULSION 35
388 FEAR 35
389 FIBROMYALGIA 35
390 HYPERSOMNIA 35
391 IRITIS 35
392 LIMB INJURY 35
393 LIP SWELLING 35
394 NON-CARDIOGENIC PULMONARY OEDEMA 35
395 NORMOCHROMIC NORMOCYTIC ANAEMIA 35
396 PRODUCT DROPPER ISSUE 35
397 SICKLE CELL ANAEMIA WITH CRISIS 35
398 VITREOUS FLOATERS 35
399 ACIDOSIS 34
400 APATHY 34
401 CRYING 34
402 CYSTOID MACULAR OEDEMA 34
403 DUST ALLERGY 34
404 ENDOPHTHALMITIS 34
405 KERATITIS 34
406 MOVEMENT DISORDER 34
407 NEURITIS 34
408 NODULE 34
409 OPEN ANGLE GLAUCOMA 34
410 UNRESPONSIVE TO STIMULI 34
411 URINARY RETENTION 34
412 BLINDNESS TRANSIENT 33
413 DEVICE ISSUE 33
414 ENCEPHALITIS 33
415 FORCED EXPIRATORY VOLUME DECREASED 33
416 HYDROCEPHALUS 33
417 JAUNDICE 33
418 LIMB DISCOMFORT 33
419 MEDICATION RESIDUE PRESENT 33
420 MITE ALLERGY 33
421 MYCOTIC ALLERGY 33
422 PRODUCT AVAILABILITY ISSUE 33
423 PULMONARY VASCULITIS 33
424 RETINAL HAEMORRHAGE 33
425 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 32
426 BLOOD GLUCOSE DECREASED 32
427 CYSTITIS 32
428 EPIDERMAL NECROSIS 32
429 ORTHOSTATIC HYPOTENSION 32
430 POLYURIA 32
431 POOR QUALITY SLEEP 32
432 RESPIRATORY SYMPTOM 32
433 SPIROMETRY ABNORMAL 32
434 SUBDURAL HAEMATOMA 32
435 TACHYPNOEA 32
436 WHITE BLOOD CELL COUNT INCREASED 32
437 ATAXIA 31
438 DIVERTICULITIS 31
439 HEPATIC ENZYME INCREASED 31
440 INJECTION SITE ERYTHEMA 31
441 MELAENA 31
442 MUSCLE TIGHTNESS 31
443 PARAESTHESIA ORAL 31
444 PRODUCT PHYSICAL CONSISTENCY ISSUE 31
445 SWELLING OF EYELID 31
446 THIRST 31
447 ULCERATIVE KERATITIS 31
448 BLOOD PRESSURE SYSTOLIC INCREASED 30
449 CEREBRAL HAEMORRHAGE 30
450 ECZEMA 30
451 ILL-DEFINED DISORDER 30
452 LIVER FUNCTION TEST ABNORMAL 30
453 RASH PRURITIC 30
454 RESTLESSNESS 30
455 RETINOPATHY 30
456 THERAPY INTERRUPTED 30
457 TOTAL LUNG CAPACITY ABNORMAL 30
458 TYPE 2 DIABETES MELLITUS 30
459 AGEUSIA 29
460 ARTHROPATHY 29
461 C-REACTIVE PROTEIN INCREASED 29
462 CONTRAINDICATED PRODUCT ADMINISTERED 29
463 EYELID IRRITATION 29
464 HIP FRACTURE 29
465 HYPHAEMA 29
466 MENTAL DISORDER 29
467 MOOD ALTERED 29
468 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29
469 NEOPLASM MALIGNANT 29
470 PNEUMOTHORAX 29
471 ROAD TRAFFIC ACCIDENT 29
472 THROAT TIGHTNESS 29
473 TUBULOINTERSTITIAL NEPHRITIS 29
474 VITREOUS HAEMORRHAGE 29
475 ACUTE MYOCARDIAL INFARCTION 28
476 CHROMATURIA 28
477 CONCOMITANT DISEASE AGGRAVATED 28
478 COVID-19 PNEUMONIA 28
479 DRUG-INDUCED LIVER INJURY 28
480 DYSSTASIA 28
481 HYPOKINESIA 28
482 INTERSTITIAL LUNG DISEASE 28
483 MENINGITIS 28
484 PERICARDIAL EFFUSION 28
485 PERIPHERAL COLDNESS 28
486 PRODUCT DELIVERY MECHANISM ISSUE 28
487 RESPIRATORY DISORDER 28
488 ANAPHYLACTIC REACTION 27
489 ASTHENOPIA 27
490 COMPLETED SUICIDE 27
491 CORONARY ARTERY DISEASE 27
492 DRUG ADMINISTRATION ERROR 27
493 DRUG EFFECT INCOMPLETE 27
494 ELECTROCARDIOGRAM QT PROLONGED 27
495 FEMUR FRACTURE 27
496 MALIGNANT NEOPLASM PROGRESSION 27
497 MYOPIA 27
498 NEURALGIA 27
499 OPTIC NEURITIS 27
500 ORAL PAIN 27
501 PALLOR 27
502 PRODUCT PRESCRIBING ISSUE 27
503 SNEEZING 27
504 THERAPY CESSATION 27
505 URINARY INCONTINENCE 27
506 WOUND 27
507 ACCIDENTAL OVERDOSE 26
508 CEREBRAL INFARCTION 26
509 EYELID DISORDER 26
510 GAIT INABILITY 26
511 GASTRIC DISORDER 26
512 GASTRITIS 26
513 HAEMATOCRIT DECREASED 26
514 INJECTION SITE HAEMORRHAGE 26
515 MIOSIS 26
516 NIKOLSKY^S SIGN POSITIVE 26
517 OPTIC NERVE INJURY 26
518 PAIN IN JAW 26
519 BLOOD COUNT ABNORMAL 25
520 BRONCHOSPASM 25
521 CLOSTRIDIUM DIFFICILE COLITIS 25
522 EAR INFECTION 25
523 FREQUENT BOWEL MOVEMENTS 25
524 GASTROENTERITIS VIRAL 25
525 IRRITABLE BOWEL SYNDROME 25
526 OSTEOARTHRITIS 25
527 PHLEBITIS 25
528 UPPER LIMB FRACTURE 25
529 ABNORMAL BEHAVIOUR 24
530 CATARACT OPERATION 24
531 CHOKING 24
532 DRY THROAT 24
533 EPIGASTRIC DISCOMFORT 24
534 JOINT INJURY 24
535 JOINT STIFFNESS 24
536 MUSCLE RIGIDITY 24
537 NEPHROGENIC ANAEMIA 24
538 NERVOUS SYSTEM DISORDER 24
539 OCULAR SURFACE DISEASE 24
540 OSTEOPOROSIS 24
541 SEASONAL ALLERGY 24
542 STAPHYLOCOCCAL INFECTION 24
543 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 23
544 APNOEA 23
545 BACTERIAL INFECTION 23
546 BLOOD UREA INCREASED 23
547 DRUG EXPOSURE DURING PREGNANCY 23
548 EYE INJURY 23
549 EYE OPERATION 23
550 EYELID PTOSIS 23
551 HEPATIC FAILURE 23
552 HEPATIC FUNCTION ABNORMAL 23
553 INJECTION SITE BRUISING 23
554 INTRAOCULAR PRESSURE FLUCTUATION 23
555 MENTAL IMPAIRMENT 23
556 OSTEOPENIA 23
557 PRODUCT PACKAGING ISSUE 23
558 PRODUCT PRESCRIBING ERROR 23
559 PRODUCT SUPPLY ISSUE 23
560 RHABDOMYOLYSIS 23
561 SHOCK 23
562 SYSTEMIC LUPUS ERYTHEMATOSUS 23
563 ANGIOEDEMA 22
564 BLOOD URINE PRESENT 22
565 BREAST CANCER 22
566 CAPILLARITIS 22
567 CLOSTRIDIUM DIFFICILE INFECTION 22
568 ERECTILE DYSFUNCTION 22
569 GOUT 22
570 GROWTH OF EYELASHES 22
571 HYPOVOLAEMIA 22
572 LEUKOCYTOSIS 22
573 MOUTH ULCERATION 22
574 PERSONALITY CHANGE 22
575 PRODUCT LABEL ISSUE 22
576 PRODUCT RESIDUE PRESENT 22
577 RESPIRATORY ACIDOSIS 22
578 SEDATION 22
579 VIRAL INFECTION 22
580 WOUND HAEMORRHAGE 22
581 BLOOD MAGNESIUM DECREASED 21
582 BLOOD SODIUM DECREASED 21
583 CARDIOGENIC SHOCK 21
584 CATHETER SITE PAIN 21
585 CIRCULATORY COLLAPSE 21
586 COAGULOPATHY 21
587 EXTRAPYRAMIDAL DISORDER 21
588 EYELID PAIN 21
589 FRACTURE 21
590 GASTROENTERITIS 21
591 IMPAIRED GASTRIC EMPTYING 21
592 INFUSION SITE ERYTHEMA 21
593 LYMPHADENOPATHY 21
594 MENINGITIS ASEPTIC 21
595 MUSCULOSKELETAL DISORDER 21
596 MYDRIASIS 21
597 NASAL DISCHARGE DISCOLOURATION 21
598 OSTEONECROSIS 21
599 RASH MACULAR 21
600 RED BLOOD CELL COUNT DECREASED 21
601 RETINAL DISORDER 21
602 RIB FRACTURE 21
603 TRANSAMINASES INCREASED 21
604 UPPER GASTROINTESTINAL HAEMORRHAGE 21
605 APHTHOUS ULCER 20
606 BODY TEMPERATURE DECREASED 20
607 CANDIDA INFECTION 20
608 COLITIS 20
609 CROHN^S DISEASE 20
610 DIABETES MELLITUS INADEQUATE CONTROL 20
611 DIABETIC KETOACIDOSIS 20
612 FOOT FRACTURE 20
613 INTESTINAL OBSTRUCTION 20
614 ISCHAEMIC STROKE 20
615 MULTIPLE-DRUG RESISTANCE 20
616 PERIORBITAL SWELLING 20
617 PHOTOPSIA 20
618 PULMONARY ARTERIAL HYPERTENSION 20
619 RASH MACULO-PAPULAR 20
620 RETINAL ARTERY OCCLUSION 20
621 SPINAL FRACTURE 20
622 ANAPHYLACTIC SHOCK 19
623 CARDIOMEGALY 19
624 DENTAL RESTORATION FAILURE 19
625 DERMATITIS 19
626 ERYSIPELAS 19
627 FACIAL PARALYSIS 19
628 FLANK PAIN 19
629 GLOMERULAR FILTRATION RATE DECREASED 19
630 HAEMORRHAGE INTRACRANIAL 19
631 HAEMORRHOIDS 19
632 HYPERAMMONAEMIA 19
633 HYPOAESTHESIA ORAL 19
634 IMPAIRED DRIVING ABILITY 19
635 INTELLECTUAL DISABILITY 19
636 KIDNEY INFECTION 19
637 MADAROSIS 19
638 METABOLIC ALKALOSIS 19
639 MULTIPLE SCLEROSIS RELAPSE 19
640 MUSCLE ATROPHY 19
641 NIGHT SWEATS 19
642 OPTIC ATROPHY 19
643 OPTIC NERVE DISORDER 19
644 PARKINSON^S DISEASE 19
645 PRE-EXISTING CONDITION IMPROVED 19
646 SKIN LESION 19
647 VITAMIN D DEFICIENCY 19
648 ACUTE RESPIRATORY DISTRESS SYNDROME 18
649 ANKLE FRACTURE 18
650 BACTERAEMIA 18
651 BENIGN INTRACRANIAL HYPERTENSION 18
652 BLOOD POTASSIUM INCREASED 18
653 BLOOD PRESSURE DIASTOLIC ABNORMAL 18
654 CONJUNCTIVAL HAEMORRHAGE 18
655 DECREASED ACTIVITY 18
656 DELUSION 18
657 DEMENTIA ALZHEIMER^S TYPE 18
658 DRUG CLEARANCE DECREASED 18
659 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18
660 FACE OEDEMA 18
661 INSURANCE ISSUE 18
662 LIVER INJURY 18
663 MALNUTRITION 18
664 MICTURITION URGENCY 18
665 PHARYNGITIS 18
666 PHOTOSENSITIVITY REACTION 18
667 PRODUCT ADMINISTRATION INTERRUPTED 18
668 PRODUCT TASTE ABNORMAL 18
669 PROSTATE CANCER 18
670 PULMONARY CONGESTION 18
671 PULMONARY HYPERTENSION 18
672 RENAL PAIN 18
673 SKIN DISORDER 18
674 SKIN ULCER 18
675 SUBARACHNOID HAEMORRHAGE 18
676 TENDERNESS 18
677 TENDON RUPTURE 18
678 THYROID DISORDER 18
679 ABDOMINAL PAIN LOWER 17
680 ABORTION SPONTANEOUS 17
681 ACIDOSIS HYPERCHLORAEMIC 17
682 ATELECTASIS 17
683 BLOOD PRESSURE ABNORMAL 17
684 CHOLELITHIASIS 17
685 DRUG EFFECT LESS THAN EXPECTED 17
686 ERUCTATION 17
687 EYE OEDEMA 17
688 GENERALISED TONIC-CLONIC SEIZURE 17
689 HYPOTHERMIA 17
690 HYPOTONY MACULOPATHY 17
691 INFUSION SITE PAIN 17
692 INJECTION SITE SWELLING 17
693 LEUKOPENIA 17
694 LIVER FUNCTION TEST INCREASED 17
695 LUNG NEOPLASM MALIGNANT 17
696 MACULOPATHY 17
697 MULTIPLE SCLEROSIS 17
698 MUSCULOSKELETAL DISCOMFORT 17
699 NASAL DRYNESS 17
700 PAROSMIA 17
701 PRODUCT DOSE OMISSION IN ERROR 17
702 RAYNAUD^S PHENOMENON 17
703 SCREAMING 17
704 SECONDARY ADRENOCORTICAL INSUFFICIENCY 17
705 SOCIAL AVOIDANT BEHAVIOUR 17
706 STATUS EPILEPTICUS 17
707 ACCIDENT 16
708 ACTIVITIES OF DAILY LIVING IMPAIRED 16
709 AGRANULOCYTOSIS 16
710 AMMONIA INCREASED 16
711 BLOOD ALKALINE PHOSPHATASE INCREASED 16
712 BODY HEIGHT DECREASED 16
713 BODY TEMPERATURE INCREASED 16
714 CARDIAC ANEURYSM 16
715 CORNEAL DEPOSITS 16
716 CORNEAL EROSION 16
717 DUODENAL ULCER HAEMORRHAGE 16
718 EYELIDS PRURITUS 16
719 FULL BLOOD COUNT DECREASED 16
720 HEMIPARESIS 16
721 HOSPICE CARE 16
722 HYPERCALCAEMIA 16
723 HYPOCALCAEMIA 16
724 INFUSION SITE SWELLING 16
725 LABORATORY TEST ABNORMAL 16
726 MALIGNANT MELANOMA 16
727 MASS 16
728 PHARYNGEAL OEDEMA 16
729 PRESCRIBED OVERDOSE 16
730 PRODUCT DEPOSIT 16
731 RESPIRATORY ALKALOSIS 16
732 RESTLESS LEGS SYNDROME 16
733 SINUS CONGESTION 16
734 SINUS DISORDER 16
735 SOPOR 16
736 ABASIA 15
737 BLEPHAROSPASM 15
738 BRAIN OEDEMA 15
739 CARDIAC FAILURE CHRONIC 15
740 CARDIOMYOPATHY 15
741 CYANOSIS 15
742 CYTOKINE RELEASE SYNDROME 15
743 EATING DISORDER 15
744 EXTRA DOSE ADMINISTERED 15
745 FAECES DISCOLOURED 15
746 FEEDING DISORDER 15
747 GASTRIC ULCER 15
748 HEPATOCELLULAR INJURY 15
749 HEPATOSPLENIC T-CELL LYMPHOMA 15
750 HERNIA 15
751 HYPERVENTILATION 15
752 HYPOTONY OF EYE 15
753 LUNG INFECTION 15
754 MOOD SWINGS 15
755 MUSCULOSKELETAL CHEST PAIN 15
756 NEUTROPHIL COUNT DECREASED 15
757 NOCTURIA 15
758 OPTIC NEUROPATHY 15
759 OSTEONECROSIS OF JAW 15
760 PEMPHIGOID 15
761 PRODUCT LEAKAGE 15
762 PRODUCT PHYSICAL ISSUE 15
763 PROSTATIC SPECIFIC ANTIGEN INCREASED 15
764 PRURITUS GENERALISED 15
765 RASH GENERALISED 15
766 REACTION TO PRESERVATIVES 15
767 RENAL TUBULAR ACIDOSIS 15
768 RESPIRATORY TRACT CONGESTION 15
769 SCRATCH 15
770 SENSITIVITY TO WEATHER CHANGE 15
771 SKIN BURNING SENSATION 15
772 SLUGGISHNESS 15
773 SPLENOMEGALY 15
774 ABNORMAL DREAMS 14
775 ABORTION INDUCED 14
776 ADRENAL INSUFFICIENCY 14
777 BLOOD CHLORIDE INCREASED 14
778 BLOOD PRESSURE SYSTOLIC ABNORMAL 14
779 CEREBROSPINAL FLUID LEAKAGE 14
780 COMPLICATIONS OF BONE MARROW TRANSPLANT 14
781 CONCUSSION 14
782 CONJUNCTIVAL OEDEMA 14
783 DRUG LEVEL INCREASED 14
784 EAR DISCOMFORT 14
785 EYE COLOUR CHANGE 14
786 FACIAL PAIN 14
787 FLAT ANTERIOR CHAMBER OF EYE 14
788 GRAND MAL CONVULSION 14
789 INITIAL INSOMNIA 14
790 LOWER LIMB FRACTURE 14
791 MUCOSAL INFLAMMATION 14
792 PHARYNGITIS STREPTOCOCCAL 14
793 PRODUCT COLOUR ISSUE 14
794 REBOUND ACID HYPERSECRETION 14
795 RETINAL VEIN OCCLUSION 14
796 SCAR 14
797 SCIATICA 14
798 SENSORY DISTURBANCE 14
799 SKIN IRRITATION 14
800 UPPER-AIRWAY COUGH SYNDROME 14
801 URINE ABNORMALITY 14
802 AFFECT LABILITY 13
803 AORTIC ARTERIOSCLEROSIS 13
804 ATRIAL FLUTTER 13
805 BLOOD ALBUMIN DECREASED 13
806 BLOOD POTASSIUM ABNORMAL 13
807 CONGENITAL INTESTINAL MALFORMATION 13
808 DEAFNESS NEUROSENSORY 13
809 DEATH NEONATAL 13
810 DERMATITIS ALLERGIC 13
811 DERMATITIS CONTACT 13
812 DEVICE BREAKAGE 13
813 DIZZINESS POSTURAL 13
814 DRUG EFFECT DECREASED 13
815 DRUG WITHDRAWAL SYNDROME 13
816 EMPHYSEMA 13
817 EOSINOPHILIA 13
818 EXTRASYSTOLES 13
819 FOETAL GROWTH RESTRICTION 13
820 GLOSSODYNIA 13
821 HEPATIC STEATOSIS 13
822 HEPATITIS 13
823 HEREDITARY ANGIOEDEMA 13
824 HIATUS HERNIA 13
825 HYDRONEPHROSIS 13
826 HYPOMAGNESAEMIA 13
827 INCREASED APPETITE 13
828 INJECTION SITE MASS 13
829 INTENTIONAL OVERDOSE 13
830 INTENTIONAL UNDERDOSE 13
831 INTERVERTEBRAL DISC DEGENERATION 13
832 IRIS ADHESIONS 13
833 LOCALISED INFECTION 13
834 LYMPHOEDEMA 13
835 NEOPLASM PROGRESSION 13
836 NEUROTOXICITY 13
837 NIKOLSKY^S SIGN TEST 13
838 OESOPHAGITIS 13
839 ORAL MUCOSAL BLISTERING 13
840 POST PROCEDURAL COMPLICATION 13
841 PREGNANCY 13
842 PRODUCT CONTAINER SEAL ISSUE 13
843 RED CELL DISTRIBUTION WIDTH INCREASED 13
844 RESPIRATORY ARREST 13
845 RETINAL OEDEMA 13
846 SINUS BRADYCARDIA 13
847 SKIN LACERATION 13
848 SPINAL COMPRESSION FRACTURE 13
849 STILLBIRTH 13
850 SUICIDE ATTEMPT 13
851 SYMPTOM MASKED 13
852 THINKING ABNORMAL 13
853 THROMBOTIC MICROANGIOPATHY 13
854 TOOTH DISORDER 13
855 TRANSFUSION 13
856 VAGINAL HAEMORRHAGE 13
857 WITHDRAWAL SYNDROME 13
858 WRIST FRACTURE 13
859 ABNORMAL LOSS OF WEIGHT 12
860 ANURIA 12
861 ASPIRATION 12
862 ATRIAL SEPTAL DEFECT 12
863 BEDRIDDEN 12
864 BLOOD BILIRUBIN INCREASED 12
865 BLOOD CREATINE PHOSPHOKINASE INCREASED 12
866 BONE MARROW FAILURE 12
867 BRADYPHRENIA 12
868 CARBON DIOXIDE DECREASED 12
869 CARDIAC FLUTTER 12
870 CEREBRAL ATROPHY 12
871 CHONDROPATHY 12
872 CONGENITAL CEREBRAL CYST 12
873 CONGENITAL HYPOTHYROIDISM 12
874 COORDINATION ABNORMAL 12
875 CRYSTALLURIA 12
876 DEVICE DIFFICULT TO USE 12
877 DISABILITY 12
878 DRUG PRESCRIBING ERROR 12
879 ENTHESOPATHY 12
880 FEELING OF DESPAIR 12
881 FOETAL HEART RATE DECELERATION ABNORMALITY 12
882 HAEMORRHAGE URINARY TRACT 12
883 HYPERLIPIDAEMIA 12
884 HYPERNATRAEMIA 12
885 HYPERPARATHYROIDISM SECONDARY 12
886 HYPOPHOSPHATAEMIA 12
887 INCORRECT PRODUCT ADMINISTRATION DURATION 12
888 INJECTION SITE PRURITUS 12
889 INTERVERTEBRAL DISC PROTRUSION 12
890 KERATIC PRECIPITATES 12
891 LEUKOENCEPHALOPATHY 12
892 ORAL HERPES 12
893 PHARYNGEAL SWELLING 12
894 POOR QUALITY PRODUCT ADMINISTERED 12
895 REBOUND EFFECT 12
896 SCAB 12
897 SENSATION OF FOREIGN BODY 12
898 SINGLE UMBILICAL ARTERY 12
899 SKIN HYPERPIGMENTATION 12
900 SKIN INFECTION 12
901 SPINAL PAIN 12
902 SUPERFICIAL INJURY OF EYE 12
903 TOOTH FRACTURE 12
904 VENTRICULAR SEPTAL DEFECT 12
905 WEIGHT FLUCTUATION 12
906 ACUTE CHEST SYNDROME 11
907 ACUTE MYOPIA 11
908 BACK INJURY 11
909 BIPOLAR DISORDER 11
910 BLOOD PRESSURE DIASTOLIC DECREASED 11
911 BOWEL MOVEMENT IRREGULARITY 11
912 BREAST CANCER FEMALE 11
913 BURKHOLDERIA TEST POSITIVE 11
914 CARDIAC TAMPONADE 11
915 CAVERNOUS SINUS THROMBOSIS 11
916 CEREBRAL VENOUS SINUS THROMBOSIS 11
917 COLITIS ISCHAEMIC 11
918 COLITIS ULCERATIVE 11
919 CORONARY ARTERY OCCLUSION 11
920 CYST 11
921 DEAFNESS UNILATERAL 11
922 DEVICE DISLOCATION 11
923 DEVICE USE ISSUE 11
924 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11
925 DRUG DISPENSING ERROR 11
926 EAR DISORDER 11
927 ECONOMIC PROBLEM 11
928 EJECTION FRACTION DECREASED 11
929 EMOTIONAL DISORDER 11
930 EXERTIONAL RHABDOMYOLYSIS 11
931 EYE MOVEMENT DISORDER 11
932 FLOPPY IRIS SYNDROME 11
933 FRUSTRATION TOLERANCE DECREASED 11
934 GAMMA-GLUTAMYLTRANSFERASE INCREASED 11
935 HALLUCINATION, AUDITORY 11
936 HORDEOLUM 11
937 HORMONE LEVEL ABNORMAL 11
938 HYPERCHOLESTEROLAEMIA 11
939 IMMUNOSUPPRESSION 11
940 IMPAIRED HEALING 11
941 INCONTINENCE 11
942 INGUINAL HERNIA 11
943 INJECTION SITE REACTION 11
944 JOINT SPACE NARROWING 11
945 LIBIDO DECREASED 11
946 LIGAMENT SPRAIN 11
947 MACULAR DETACHMENT 11
948 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 11
949 MITRAL VALVE INCOMPETENCE 11
950 MOUTH HAEMORRHAGE 11
951 MYOTONIA 11
952 NERVE INJURY 11
953 NIKOLSKY^S SIGN 11
954 ORAL CANDIDIASIS 11
955 PANIC REACTION 11
956 PERICARDIAL HAEMORRHAGE 11
957 PERITONITIS 11
958 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11
959 PROTEINURIA 11
960 PSYCHIATRIC SYMPTOM 11
961 RESPIRATORY RATE INCREASED 11
962 RETINAL DEGENERATION 11
963 SALIVARY HYPERSECRETION 11
964 SINUS TACHYCARDIA 11
965 TOXIC ENCEPHALOPATHY 11
966 VITREOUS OPACITIES 11
967 VITRITIS 11
968 ANTERIOR CHAMBER DISORDER 10
969 APHONIA 10
970 BLOOD CALCIUM DECREASED 10
971 BLOOD IRON DECREASED 10
972 BLOOD PHOSPHORUS DECREASED 10
973 BREATH SOUNDS ABNORMAL 10
974 CARDIAC VALVE DISEASE 10
975 CARDIOPULMONARY FAILURE 10
976 CLEAR CELL RENAL CELL CARCINOMA 10
977 CORNEAL EPITHELIUM DEFECT 10
978 CORNEAL INFECTION 10
979 CUSHING^S SYNDROME 10
980 DEFAECATION URGENCY 10
981 DEVICE LEAKAGE 10
982 DIABETIC RETINOPATHY 10
983 DISSEMINATED INTRAVASCULAR COAGULATION 10
984 DROOLING 10
985 EUGLYCAEMIC DIABETIC KETOACIDOSIS 10
986 FAMILIAL PERIODIC PARALYSIS 10
987 FEELING JITTERY 10
988 FLUID INTAKE REDUCED 10
989 FOETAL DEATH 10
990 FOREIGN BODY IN EYE 10
991 HAEMOLYSIS 10
992 HAIR TEXTURE ABNORMAL 10
993 HALLUCINATIONS, MIXED 10
994 HICCUPS 10
995 HUNGER 10
996 HYPERAEMIA 10
997 HYPERVOLAEMIA 10
998 HYPOCHLORAEMIA 10
999 IMMUNE SYSTEM DISORDER 10